ASXL1 and acute myeloid leukemia: Mutations in ASXL1 have predominantly been investigated in the context of hematologic malignancies, such as acute myeloid leukemia (AML) (Asada et al. 2019; Gao et al. 2022; Yang and Agosto-Peña 2023).